Pharmacological inhibition of the interleukin‐1 receptor‐associated kinase prevents angiotensin II‐induced cardiac remodelling in mice

Documenti analoghi

• The NADPH oxidase inhibitor Vas2870 prevents myocyte ferroptosis and improves cardiac remodelling and function in doxorubicin‐induced cardiomyopathy
  di: Jing Wang, et al.
  Pubblicazione: (2026)
• Atrial natriuretic peptide counteracts aldosterone secretion by preventing acute angiotensin II‐induced cAMP signalling
  di: Sanika Mohagaonkar, et al.
  Pubblicazione: (2026)
• Dual pharmacological targeting of coactivator‐associated arginine methyltransferase 1 (CARM1) and salt inducible kinase (SIK) drives ketogenesis in both hepatocytes and mice
  di: Tábata Bergonci, et al.
  Pubblicazione: (2026)
• A novel selective stabilizer of the ryanodine receptor 2 prevents stress‐induced ventricular arrhythmias without impairing cardiac function
  di: Nagomi Kurebayashi, et al.
  Pubblicazione: (2026)
• Circular RNA regulatory role in pathological cardiac remodelling
  di: Alessia Bibi, et al.
  Pubblicazione: (2024)